Publication:
The efficacy of dexamethasone sodium phosphate compared to triamcinolone acetonide in the treatment of carpal tunnel syndrome: A randomized double-blind controlled trial

dc.contributor.authorDilokhuttakarn T.
dc.contributor.authorLertnantapanya S.
dc.contributor.authorVechmamontien S.
dc.contributor.authorSuwanchatchai C.
dc.date.accessioned2021-04-05T03:05:05Z
dc.date.available2021-04-05T03:05:05Z
dc.date.issued2018
dc.date.issuedBE2561
dc.description.abstractBackground: Corticosteroid injections have been used in carpal tunnel syndrome (CTS). However, there have been reported side effects associated with the drugs. Dexamethasone sodium phosphate has been studied to cause fewer side effects and the least neurotoxic agent. However, evidence of the efficacy of dexamethasone sodium phosphate in CTS is still lacking. Objective: To compare the efficacy of dexamethasone sodium phosphate and triamcinolone acetonide in the treatment of CTS and observe their complications. Materials and Methods: A prospective randomized double-blind controlled trial study was performed between January and December 2015 at HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University in Nakhon Nayok province. Patients with CTS were randomly assigned into two groups based on the mode of treatment with either dexamethasone sodium phosphate or triamcinolone acetonide. Results of treatment were measured via hand grip power, positive Phalen’s test time, Global Symptom Score for Carpal Tunnel Syndrome (GSS), Disability of Arm, Shoulder, and Hand Questionnaire (DASH) score. Negative outcome in patients that required surgery and the complications were also recorded. Results: Sixty patients with CTS were randomly assigned into two groups [dexamethasone sodium phosphate group (n = 30) and triamcinolone acetonide group (n = 30)]. There was no difference of demographic data between the two groups. The dexamethasone sodium phosphate group improved significantly in positive Phalen’s test time (mean difference-5.53; 95% confidence interval-0.56 to-10.50, p=0.029). In other measurement, the dexamethasone sodium phosphate group had better scores and had a lower number of patients who required and underwent surgery, but there was no significant difference between the two groups (p>0.05). No serious complication was detected at the time of follow-up. Conclusion: In the treatment of CTS by corticosteroid injection, dexamethasone sodium phosphate was effective and improved significantly in positive Phalen’s test time, compared to those treated with triamcinolone acetonide, which was widely prescribed. No serious complication was detected in either groups. © 2018, Medical Association of Thailand. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 101, No.12 (2018), p.1634-1639
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85060233637
dc.identifier.urihttps://hdl.handle.net/20.500.14740/5756
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.otherDexamethasone sodium phosphate
dc.subject.otherTriamcinolone acetonide
dc.subject.otherAdult
dc.subject.otherArticle
dc.subject.otherCarpal tunnel syndrome
dc.subject.otherComparative study
dc.subject.otherControlled study
dc.subject.otherDisease severity
dc.subject.otherDouble blind procedure
dc.subject.otherDrug efficacy
dc.subject.otherFemale
dc.subject.otherFollow up
dc.subject.otherGrip strength
dc.subject.otherHand grip
dc.subject.otherHuman
dc.subject.otherInjection site swelling
dc.subject.otherMajor clinical study
dc.subject.otherMale
dc.subject.otherMiddle aged
dc.subject.otherMuscle atrophy
dc.subject.otherNerve conduction
dc.subject.otherProspective study
dc.subject.otherQuestionnaire
dc.subject.otherRandomized controlled trial
dc.subject.otherSensation
dc.subject.otherSkin redness
dc.subject.otherTreatment outcome
dc.titleThe efficacy of dexamethasone sodium phosphate compared to triamcinolone acetonide in the treatment of carpal tunnel syndrome: A randomized double-blind controlled trial
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85060233637&partnerID=40&md5=0b2b44df881145f9e7e34a8cd2f4987c

Files